5.300USD+1.53%Mkt Cap: 10.18M USDP/E: —Last update: 2026-06-01
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that t…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap10.18M USD
Enterprise Value9.50M USD
Revenue (TTM)6.50M USD
Gross Profit-22.03M USD
Net Income (TTM)-33.38M USD
Revenue/Share3.589 USD
Last Price5.300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0977021049
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA-0.33
EV/Revenue1.46
P/S1.55
P/B0.51
EPS (TTM)-16.40
EPS (Forward)-254.96
52W Range
3.91040% of range7.350
52W High7.350 USD
52W Low3.910 USD
Profitability
Gross Margin0.00%
Oper. Margin-29234.62%
EBITDA Margin0.00%
Profit Margin-433.74%
ROE-125.92%
ROA-58.81%
Growth
Revenue Growth-97.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.85M USD
CapEx (TTM)72.00K USD
FCF Margin-322.87%
FCF Yield-206.04%
Net Debt-584.00K USD
Net Debt/EBITDA0.02
Balance Sheet
Debt/Equity0.87
Current Ratio3.51
Quick Ratio3.12
Book Value/Sh10.32 USD
Cash/Share11.91 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 9, 2025
Analyst Consensus
Rating—
Target (Mean)41.00 USD
Target Range7.000 USD – 75.00 USD
# Analysts2
Ownership
Shares Out.1.92M
Float1.77M
Insiders7.10%
Institutions28.86%
Short Interest
Short Ratio0.4d
Short % Float0.63%
Short % Out.0.63%
Shares Short12.13K
Short (prev mo.)22.70K
Technical
SMA 504.736 (+11.9%)
SMA 2005.185 (+2.2%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)31.24K
Avg Vol (10d)34.06K
Technical Indicators
RSI (14)58.7
MACD0.0973
MACD Signal0.0369
MACD Hist.+0.0604
BB Upper5.349 USD
BB Middle4.837 USD
BB Lower4.325 USD
BB Width21.17%
ATR (14)0.3791 USD
Vol Ratio (20d)0.73x